Article
Genomic landscape of metastatic colorectal cancer
14 Nov 2014
Abstract excerpt
Response to drug therapy in individual colorectal cancer (CRC) patients is associated with tumour biology. Here we describe the genomic landscape of tumour samples of a homogeneous well-annotated series of patients with metastatic CRC (mCRC) of two phase III clinical trials, CAIRO and CAIRO2. DNA copy number aberrations of 349 patients are determined. Within three treatment arms, 194 chromosomal subregions are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
